Delisting riskPopularity #4,455
KALA BIO (KALA)
Evaluates biotech AI infrastructure while preserving biologics assets for potential partners.
$0.5800
After hours−0.02 (−3.17%)
At close$0.5990(+6.96%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 0.18% | 34.0K shares | |
|---|---|---|---|
| 26 holders · as of Mar 31, 2026 | |||
| Insiders | 0.03% | 6.3K shares | |
| 10 holders · as of Oct 24, 2025 | |||
| Strategic holders | 0.22% | 41.8K shares | |
| 2 holders · as of Dec 3, 2025 | |||
| Other | 99.57% | 19.26M shares | |
| remainder | |||
19.34M company shares as of Sep 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
13F, as of Mar 31, 2026
26 holders · 1.70M shares · 8 new positions · 16 increased · 2 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Renaissance Technologies LLC | 417.5K | 2.16% | +376.6K | May 14, 2026 |
| Citadel Advisors LLC | 281.7K | 1.46% | +225.3K | May 15, 2026 |
| Geode Capital Management, LLC | 261.1K | 1.35% | +199.9K | May 15, 2026 |
| Virtu Financial LLC | 152.2K | 0.79% | +66.7K | May 14, 2026 |
| Adar1 Capital Management, LLC | 141.5K | 0.73% | 0 | May 18, 2026 |
| Gsa Capital Partners LLP | 84.5K | 0.44% | +84.5Knew | May 8, 2026 |
| UBS Group AG | 66.9K | 0.35% | +43.0K | May 5, 2026 |
| Vanguard Capital Management LLC | 60.5K | 0.31% | +60.5Knew | May 15, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Oxford Finance LLC | 16.50% | 13G | Dec 3, 2025 | |
| Baker Bros. Advisors LP | 9.99% | 13G | Feb 17, 2026 | |
| Baker Bros. Advisors (GP) LLCincl. Felix J. Baker, Julian C. Baker +1 more | 9.99% | 13D | Oct 2, 2025 | |
| ADAR1 Capital Management GP, LLCincl. ADAR1 Capital Management, LLC, Daniel Schneeberger | 9.99% | 13G | Nov 14, 2024 | |
| LifeSci Capital LLC | 7.90% | 13G | Jan 13, 2026 | |
| David E. Lazar | 5.18% | 13D | Feb 6, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Oct 22, 2025 | Darius Kharabiofficer: CHIEF BUSINESS OFFICER | Sale | 20,806 | $0.8300 | 41,760 |
| Oct 22, 2025 | Romulus K. Brazzellofficer: SEE REMARKS | Sale | 46,748 | $0.8300 | 35,952 |
| Oct 22, 2025 | Todd Bazemoredirector | Sale | 47,768 | $0.8300 | 35,932 |
| Oct 23, 2025 | Mary Reumuthofficer: CHIEF FINANCIAL OFFICER | Sale | 967 | $0.8200 | 28,906 |
| Oct 22, 2025 | Mary Reumuthofficer: CHIEF FINANCIAL OFFICER | Sale | 32,230 | $0.8300 | 29,873 |
| Oct 23, 2025 | Mark T. Iwickidirector | Sale | 154,894 | $0.8100 | 103,540 |
| Oct 1, 2025 | Baker Bros. Advisors LPother: Former 10% owner | Sale · 2 lots | 513,607 | $1.38 | 46,480 |
| Sep 30, 2025 | Baker Bros. Advisors LPother: Former 10% owner | Sale · 2 lots | 216,801 | $1.60 | 97,120 |
House and Senate disclosures
Not reported.